A Study of PER-001 in Participants With Diabetic Retinopathy

NCT06003751 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: PER-001 Intravitreal Implant - Low Dose
DRUG: PER-001 Intravitreal Implant - High Dose
DRUG: PER-001 Intravitreal Implant - Sham

Sponsor

Perfuse Therapeutics, Inc.